Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Protective Effects of PGC-1α via the Mitochondrial Pathway in Rat Brains after Intracerebral Hemorrhage.
MRI as an outcome in multiple sclerosis clinical trials.
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients.
Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
The influence of nutritional factors on the prognosis of multiple sclerosis.
MRI in multiple sclerosis: current status and future prospects.
No shortcuts to outcome in MS clinical trials?
Pediatric Lyme Neuroborreliosis: Different clinical presentations of the same agent; Single center experience.
One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis.
Cost Analysis of the Use of Glatiramer Acetate Compared to Interferon-Â in Patients with Relapsing-Remitting Multiple Sclerosis and Spasticity in Spain.
Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II.
Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis.
The Relationships among MRI-Defined Spinal Cord Involvement, Brain Involvement, and Disability in Multiple Sclerosis.
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
Preferential Use of Public TCR during Autoimmune Encephalomyelitis.
Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
Gray matter imaging in multiple sclerosis: what have we learned?
Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study.
Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis.
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Gray matter atrophy in multiple sclerosis: a longitudinal study.
Advanced MRI and staging of multiple sclerosis lesions.
MRI as an outcome in multiple sclerosis clinical trials.
Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.

Pages